MimiVax has exceeded my expectations in every way. The website is user-friendly and the services provided are exceptional. I am truly grateful for their expertise and would highly recommend them to others.
Questions about MimiVax
What is MimiVax?
MimiVax is a privately-held, clinical-stage biotechnology company headquartered in Buffalo, New York, that develops and commercializes immunotherapeutic vaccines and targeted therapies for cancer treatment.
How long has MimiVax existed and what is its team structure?
The company was founded in 2012 and has been operating for 15 years as of 2026, focusing on bench-to-bedside research to close the lab-to-clinic gap.
What specific product does MimiVax offer and what certifications does it have?
Their lead investigational product is SurVaxM, a survivin-targeting vaccine engineered specifically for glioblastoma, which holds Orphan Drug and Fast Track federal designations.
What is the mechanism behind MimiVax's vaccine technology?
The vaccine targets the survivin protein, a cell-survival protein present in most cancers, to enable healthcare providers to cure their patients.
What were the key results from the SURVIVE trial?
The SURVIVE Phase 2b trial showed that patients 65 and under lived a median of 24.2 months versus 20.2 months on placebo, achieving statistical significance in overall survival benefit.
How many patients were involved in the SURVIVE trial and what were the survival rates?
The trial included 233 patients, with 42% alive at 30 months or longer on SurVaxM compared to 18% on placebo for those 65 and under.
Where is MimiVax located and how does its location relate to its operations?
The company is located at Elm & Carlton Streets in Buffalo, NY, alongside the clinical environment where SurVaxM began.
How can patients and caregivers get started with MimiVax's services?
Patients and caregivers seeking expanded access to SurVaxM should start with the company's Expanded Access page, as requests outside of a clinical trial follow a separate process.
What is the current regulatory status of MimiVax's vaccine?
The website states that SurVaxM is an investigational product that has not been approved by the FDA or any other regulatory authority.
What is MimiVax's mission and what makes it different from competitors?
The company's mission is to disrupt cancer with the development of highly innovative immunotherapies aimed at increasing patient survival rates.
What information does MimiVax provide to investors and medical professionals?
The company's website highlights that it provides information on its pipeline, clinical trials, and leadership team for investors and medical professionals.
What is the Trustburn rating and how recent are the reviews?
The Trustburn rating is 4.1 out of 5 from 8 reviews, with the most recent reviews from October 2023 praising the website's user-friendliness and exceptional services.
What do reviewers praise about MimiVax?
Reviewers consistently praised the website for being easy to navigate, informative, and user-friendly, while noting the company's professionalism and promptness.
How does MimiVax's approach differ from other glioblastoma therapies?
The company uses a survivin-targeting technology that is distinct from prior glioblastoma therapies that were adapted from other cancers.
What is the official website of MimiVax?
The official website of MimiVax is mimivax.com.
AI-generated from reviews on this page. Verify anything important with the company directly.
I recently utilized the services provided by mimivax.com and was impressed by their professionalism and promptness. The website was easy to navigate and the service was of high quality. I would definitely recommend their services to others.
👍 I cannot express how satisfied I am with the services offered by MimiVax. Their website is informative and their customer service is top-notch. I would definitely recommend them to anyone seeking their expertise. 👍
I recently used the services offered by mimivax.com and was extremely pleased. The website was easy to navigate and the service was prompt and professional. I would definitely use them again in the future.
😊 My experience with MimiVax has been truly wonderful. The website is easy to use and the services provided are exceptional. I am extremely happy with the level of expertise and professionalism exhibited by the company. 😊
I have had a great experience with MimiVax. The website is informative and the services offered are of the highest quality. I am extremely satisfied and would highly recommend their services to others.
The services provided by MimiVax are excellent. The website is user-friendly and informative. The company's dedication to research and development is evident. I would highly recommend MimiVax to anyone in need of their services.
👌 I recently availed the services of MimiVax and I must say that they exceeded my expectations. The website is easy to navigate and the services offered are excellent. I would absolutely recommend them. 👌
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About MimiVax
MimiVax is a privately-held, clinical-stage biotechnology company that focuses on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. Its vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers that enable healthcare providers to cure their patients.
The company was founded in 2012 and is headquartered in Buffalo, New York.
- Website
- mimivax.com